oxacillin has been researched along with ly-146032 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (75.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Cui, L; Hiramatsu, K; Matsuo, M; Neoh, HM; Takeuchi, F; Yuzawa, H | 1 |
| Clark, NC; Hageman, J; McDonald, LC; McDougal, LK; Patel, JB; Zhu, W | 1 |
| Baltch, AL; Bopp, LH; Michelsen, P; Ritz, WJ; Smith, RP | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Biek, D; Ge, Y; Sahm, DF; Talbot, GH | 1 |
| Camargo, IL; Cui, L; Hiramatsu, K; Neoh, HM | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
| Chen, FJ; Huang, IW; Lauderdale, TL; Lee, CH; Wang, MC | 1 |
| Camargo, IL; Cui, L; Fukuda, M; Hiramatsu, K; Hishinuma, T; Isii, T; Neoh, HM; Ochiai, T; Shoji, M; Watanabe, Y | 1 |
| Antunes, NT; Boudreau, MA; Chang, M; Ding, D; Lastochkin, E; Leemans, E; Lichtenwalter, K; Mobashery, S; O'Daniel, PI; Peng, Z; Pi, H; Schroeder, VA; Song, W; Spink, E; Suckow, MA; Testero, SA; Vakulenko, S; Wolter, WR | 1 |
| Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for oxacillin and ly-146032
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for oxacillin and ly-146032
| Article | Year |
|---|---|
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Phenotype; Sequence Analysis, DNA; Signal Transduction; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Humans; Michigan; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
Topics: Anti-Bacterial Agents; Cells, Cultured; Daptomycin; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcus aureus | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 2008 |
Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Humans; Membrane Fluidity; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Phenotype; Vancomycin | 2008 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Oxazolidinones; Teicoplanin; Vancomycin Resistance | 2010 |
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Multiple, Bacterial; Mutation; Polymorphism, Single Nucleotide; Staphylococcus aureus; Vancomycin | 2010 |
Structure-activity relationship for the oxadiazole class of antibiotics.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Staphylococcus aureus; Structure-Activity Relationship | 2015 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |